跳至主要内容
临床试验/CTRI/2025/12/099754
CTRI/2025/12/099754尚未招募不适用

TO UNDERSTAND THE MIASMATIC BACKGROUND OF GASTRO OESOPHAGEAL REFLUX DISEASE (GERD) AND ITS HOMOEOPATHIC MANAGEMENT

DR DARSHAN JADAV1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年12月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1

研究概览

简要总结

THE STUDY TITLED "MIASMATIC DIAGNOSIS OF GASTRO OESOPHAGEAL REFLUX DISEASE(GERD) AND IT’S HOMOEOPATHIC MANAGEMENT" A CLINICAL VERIFICATION STUDY DESIGNED TO SCIENTIFICALLY EXAMINED HOW EFFECTIVE THE MIASMATIC DIAGNOSIS IS IN TREATING CLINICALLY CONFIRMED CASES OF GASTRO OESOPHAGEAL REFLUX DISEASE (GERD) THEY ARE USUALLY TREATED WITH CONVENTIONAL THERAPIES BUT THESE TREATMENTS OFTEN GIVE TEMPORARY OR SYMPTOMATIC RELIEF. HOMOEOPATHY WITH IT’S HOLISTIC AND INDIVIDUALIZED, ANTI MIASMATIC TREATMENT OFFERS AN ALTERNATIVE OPTION. MIASMATIC DIAGNOSIS OF GERD WILL HELP THE PATIENTS MORE EFFICIENTLY IN HOMOEOPATHIC MANAGEMENT.

THIS ANALYTICAL, INTERVENTIONAL UNCONTROLLED CLINICAL TRIAL WILL BE CARRIED OUT OVER A PERIOD OF 9 MONTHS AT BARODA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL, VADODARA. THE STUDY WILL USE PURPOSIVE SAMPLING OF 30 PATIENTS, CLINICAL ASSESSMENT WILL BE DONE USING THE GERD Q SCORE SYSTEM.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
12.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • ALL AGE GROUPS (CHILDREN, ADULTS, ELDERS) AND BOTH SEXES WITH CINICALLY PRE-DIAGNOSED CASES OF GASTRO OESOPHAGEAL REFLUX DISEASE (GERD).
  • CASES WITH FUNCTIONAL CHANGES OR WITH REVERSIBLE PATHOLOGY.
  • PATIENTS WHO HAVE WILLINGNESS TO PARTICIPATE.

排除标准

  • THE CASES WITH ACUTE EMERGENCY, CONGENITAL ANOMALY, SEVERE SYSTEMIC ILLNESS AND SEVERE IRREVERCIBLE PATHOLOGICAL CHANGES.
  • THE CASES WHICH DID NOT MAINTAIN A REGULAR FOLLOW UP.

研究者

发起方
DR DARSHAN JADAV
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

DR DARSHANKUMAR JADAV

BARODA HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL

研究点 (1)

Loading locations...

相似试验